Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Colorectal Neoplasms 13 Carcinoma, Hepatocellular 7 Neoplasms 3 Liver Neoplasms 2 Glioblastoma 2 Gastrointestinal Stromal Tumors 2 Colonic Neoplasms 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Recurrence 1 Rectal Neoplasms 1 Piebaldism 1 Patient Compliance 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Microsatellite Stable Metastatic Colorectal Cancer 1 Meningioma 1 Melanoma 1 MCRC 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Liver Metastases 1 Leiomyosarcoma 1

Interventions

Cyclophosphamide 22 fludarabine 20 venetoclax 8 Whole-Body Irradiation 8 Mycophenolic Acid 8 Standard of Care 6 Mesna 6 Melphalan 6 Azacitidine 6 fludarabine phosphate 5 Sirolimus 5 thymoglobulin 4 Thiotepa 4 Tacrolimus 4 Specimen Handling 4 Filgrastim 4 Cytarabine 4 entrectinib 3 daratumumab 3 cobimetinib 3 alectinib 3 Vemurafenib 3 Surveys and Questionnaires 3 Rituximab 3 Practice Guidelines as Topic 3 Palliative Care 3 Granulocyte Colony-Stimulating Factor 3 Busulfan 3 Bortezomib 3 Blood Specimen Collection 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Hematologic Neoplasms × regorafenib × Clear all

NCT05159245 2024-07-15

FINPROVE

Helsinki University Central Hospital

Phase 2 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡